Drug
Lecanemab
Lecanemab: highest development phase Phase 3, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lecanemab IV NCT03887455 | Phase 3 | Early Alzheimer's Disease |
Latest
No recent events.
Follow Lecanemab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.